Health Canada NHP Licensing
End-to-end NPN (Natural Product Number) dossier preparation, Compendial and Non-Compendial submissions, and Site License compliance for the Canadian market.
Comprehensive Health Canada NHP licensing, US FDA dietary supplement compliance, EU food supplement notifications, and global market authorization dossiers.
Navigating international regulatory frameworks is one of the most critical challenges in the dietary supplement industry. Q Nutritions provides full-scope regulatory affairs management to streamline product clearance across more than 40 countries. Our dedicated team of regulatory specialists, pharmacologists, and quality assurance engineers ensures your formulas, safety data, and label claims align precisely with regional regulations.
From Health Canada Natural Health Product (NHP) Site and Product Licensing (NPN) to US FDA dietary supplement notifications and EU Novel Food evaluations, we eliminate compliance roadblocks and minimize market entry timelines for global distributors and clinical brand owners.
Our regulatory strategists manage compliance workflows across major international health authorities to keep your brand audit-ready.
End-to-end NPN (Natural Product Number) dossier preparation, Compendial and Non-Compendial submissions, and Site License compliance for the Canadian market.
Facility registration, DUNS management, Structure/Function claim notifications under DSHEA, NDI (New Dietary Ingredient) reviews, and 21 CFR 111 cGMP auditing.
EU Directive 2002/46/EC notifications, EFSA health claim substantiation, Novel Food status evaluation, and post-Brexit UK FSA compliance filing.
Rigorous verification of Supplement Facts, active ingredient levels, allergen warnings, ingredient naming (INCI/PIN), and compliant advertising copy.
Dossier compilation for UAE MoHAP, Saudi Food & Drug Authority (SFDA), Australia TGA complementary medicine listings, and LATAM health filings.
Proactive tracking of evolving international regulations, ingredient restriction updates, and maximum daily dose shifts to protect your SKUs long-term.
Our regulatory expertise is backed by robust documentation standards and decades of hands-on experience in regulated production.
A systematic compliance process engineered to minimize risk and secure market authorization on schedule.
We audit your formulation, active ingredients, and target markets to define the exact regulatory pathway and requirement matrix.
Our team compiles technical safety data, raw material specifications, finished-goods testing protocols, and compliant label copy.
Formal submission filing with Health Canada, US FDA, or international health bodies, accompanied by active agency liaison.
Official license issuance (NPN/DIN-HM) combined with ongoing lifecycle monitoring and regulatory renewal management.
Technical clarity on supplement registration, timelines, and export documentation.
Timelines depend on the submission category. Compendial (Class 1) applications following established Health Canada monographs are generally processed within 60 days. Non-compendial (Class 2 and Class 3) custom formulations requiring specialized safety and efficacy data review typically take between 90 and 180 days. Our thorough pre-submission verification ensures complete documentation to eliminate deficiency notices.
Under the Dietary Supplement Health and Education Act (DSHEA), dietary supplements do not require pre-market approval from the US FDA. However, brand owners and contract manufacturers must comply with mandatory facility registration, 21 CFR Part 111 cGMP standards, accurate Supplement Facts labelling, and submit 30-day post-market notifications for all Structure/Function claims.
Yes. We prepare comprehensive export dossiers for over 40 destination markets. This includes food supplement notification files for EU member states (under Directive 2002/46/EC), product registration filings for the UAE Ministry of Health and Prevention (MoHAP), Saudi Food and Drug Authority (SFDA) registration, and Australian TGA complementary medicine listings.
Every commercial production run is accompanied by an audit-ready compliance package: Certificate of Analysis (COA), Certificate of Free Sale (FSC), Certificate of Origin (COO), certified GMP copies, Allergen & Non-GMO Statements, and Safety Data Sheets (SDS) to guarantee efficient clearance at destination customs.
Our regulatory team evaluates peer-reviewed clinical studies and scientific literature to support targeted health claims. We verify active marker concentrations, bio-equivalent dosing, and global regulatory guidelines (such as Health Canada NHP monographs, US FDA structure/function guidance, and EFSA opinions) to ensure all marketing copy remains fully defensible.
Consult with our regulatory specialists to evaluate your product formulation, claim substantiation, and international registration roadmap.